MedPath

Prospective Analysis of Introperative RegenLab PRP and Hyaluronic Acid in Patients With Knee ACL Tear

Phase 4
Conditions
Hyaluronic Acid
ACL
PRP
Registration Number
NCT04586361
Lead Sponsor
Kaohsiung Veterans General Hospital.
Brief Summary

Purpose: The purpose of this article is to examine the clinical application of PRP and PRP+hyaluronic acid in disorders in the knee.

Methods:

The study was conducted on 150 adult patients with age over 20 years old affected by unilateral ACL complete tear and receiving ACL reconstruction. We divided the patients in three groups, and we treated the group A with perioperative injection of HHA, group B with perioperative HHA+PRP, group C with perioperative normal saline.

Follow-up:

Every 1,3,and 12months, we recheck physical exmianation at OPD and recheck MRI at postoperative 3 months.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
150
Inclusion Criteria
  • receiving unilateral ACL reconstruction in our hospital
  • postoperative follow-up over 3 month
Exclusion Criteria
  • postoperative follow-up less than 3 month
  • possible pregnency
  • with coagulation disease
  • NSAIDs intake during study period

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
150 of participants with preoperative and postoperative Magnetic Resonance Imaging are accessedpostoperative 3 month

anterior cruciate ligament was accessed by MRI T1 and T2 image; MRI was checked by one orthopedist

150 of participants with preoperative and postoperative physical examination are accessed by anterior drawer test and Lachman testpostoperative 12 months

the investigators recheck physical exmianation of participants at OPD; physical examination was checked by one orthopedist

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Kaohsiung Veterans General Hospital

🇨🇳

Kaohsiung, 高雄市, Taiwan

Kaohsiung Veterans General Hospital
🇨🇳Kaohsiung, 高雄市, Taiwan
Yi Ping Wei, MD
Contact
073422121
xgoznas22@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.